Ascorbate is a pro-oxidant in chromium-treated human lung cells.

Area of Science:

• Toxicology
• Cell Biology
• Environmental Health

Background:

• Inhalation of hexavalent chromium targets the lungs, necessitating models to study its toxicity.
• Reductive activation of chromium within cells is crucial for its reaction with cellular components.
• Fluorescent dyes like dichlorofluorescein (DCF) and dihydrorhodamine detect chromium activation and reactive species formation.

Purpose of the Study:

• To investigate the roles of glutathione and ascorbic acid (Vitamin C) in generating reactive chromium species (RCS) intracellularly.
• To understand how manipulating these reductants affects chromium-induced oxidative stress in A549 lung cells.

Main Methods:

• Utilized the human A549 lung cell line as a model system.
• Manipulated intracellular glutathione levels using buthionine sulfoximine (BSO).
• Altered ascorbic acid levels by adding ascorbate to culture media.
• Measured intracellular oxidation using fluorescent indicators (DCF, dihydrorhodamine).

Main Results:

• High endogenous glutathione levels in A549 cells reduced basal oxidation.
• Decreasing glutathione with BSO increased both background and chromium-stimulated oxidation.
• Ascorbic acid addition exacerbated chromium-induced oxidative stress, acting as a pro-oxidant.

Conclusions:

• Ascorbic acid functions as a pro-oxidant in chromium-treated lung cells.
• Glutathione plays a significant role in mitigating chromium-induced oxidative damage.
• Understanding these interactions is key to addressing chromium toxicity in lung tissues.